Neurofeedback-Assisted Mindfulness Techniques to Reduce Symptoms of Mental Distress (ComBiNe)

March 15, 2024 updated by: Kaat Alaerts, KU Leuven

Combining Novel Bio-Neurofeedback Techniques With Mindfulness-Based Interventions to Reduce Symptoms of Mental Distress

Neurofeedback training, based on operant conditioning techniques, involves the measurement and conscious regulation of specific neural parameters through participant-specific feedback. This technique has gained recognition for its role in efficiently altering brain activity. Among its various applications, neurofeedback training is noted for its ability to facilitate meditative practice and enhance stress regulation abilities. However, most neurofeedback studies focus on modulating isolated brainwaves and overlook how brainwaves interact across frequencies. To address this gap, the present study will evaluate an intervention that combines meditation techniques with a novel cross-frequency neurofeedback training to enhance the outcomes of meditative practice for stress regulation.

Previous research has established that brain rhythms exhibit interactive patterns, forming harmonic and non-harmonic relationships to respectively facilitate and preclude cross-frequency coupling. Harmonic relationships are essential for the synchronization of oscillations, a process necessary for coordinating complex neural and physiological activities. In contrast, non-harmonic relationships result in a highly desynchronized state characterized by reduced neural and physiological coordination, typically observed during cognitive restful periods. In this regard, prior studies have demonstrated a link between an increased occurrence of non-harmonic alpha-theta ratios and mindfulness meditation.

Recent research has shown the possibility of upregulating the incidence of non-harmonic alpha-theta ratios during mindfulness meditation in a single-session neurofeedback training context. However, the impact of long-term training on stress regulation abilities remains unclear. The current study addresses this gap by conducting a 10-session neurofeedback training focused on upregulating the incidence of non-harmonic alpha-theta ratios during focused attention meditation. The primary aim of this study is to determine the effectiveness of this training in assisting mindfulness practice and improving stress regulation as assessed by a range of neurophysiological, psychological, and biological outcomes.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The present study is a single-blind, randomized-controlled clinical trial involving 80 healthy, meditation-naïve adults. All participants will be randomly assigned to either take part in experimental neurofeedback training or control (sham) neurofeedback training. Each training consists of 10 training sessions, with a frequency of 2 sessions per week (i.e., 5 weeks total training duration).

During each neurofeedback training session, participants will sit in front of a computer screen in a dimly lit room. Each training session will start and finish with a self-report mood assessment (POMS) and a 2-minute neural resting-state recording. In-between, participants will take part in 10 consecutive 2-minute neurofeedback trials. During these trials, participants are instructed to close their eyes and focus their attention on a specific point of their body (i.e., an anchor point). Simultaneously, neural recordings will be made, and reinforcing auditory cues will be presented upon the measurement of non-harmonic ratios between alpha and theta rhythms at the Pz channel. Participants are informed that the feedback sounds serve as positive feedback for their ability to engage in a neurophysiological state associated with meditative practice for stress regulation, and that this sound will assist their body in self-regulating to sustain this desired state. The sham training will be indistinguishable from the experimental biofeedback training for the participants involved. However, during the sham training, auditory cues will be unrelated to the participant's underlying brain activity, presented at random timepoints and therefore, no specific training can occur. After every two training trials, participants will be asked to indicate their levels of focus, sleepiness, and relaxation.

We will measure psychological, neurophysiological, and biological mental health outcomes before the start of the training (T0), following the end of the training (T1), and again at the 5-week follow-up (T2).

During these three assessment points, participants will complete self-report questionnaires on emotional distress (DASS), mindfulness skills (CHIME), perceived stress (PSS), repetitive negative thinking (PTQ), and sleep quality (PSQI). Next, neurophysiological measurements will be made during a 5-minute eyes-closed resting state recording, during a 10-minute eyes-closed focused attention meditation, and during eyes-closed stress induction (3 min) and recovery (17 out of 57 min). Stress will be induced by utilizing the cold pressor task procedure which involves the participant submerging their hand into cold water (0-2°C) for a duration of three minutes while being perceived to be recorded by a video camera. Cortisol samples will be obtained right before the stress induction (T0), during the expected cortisol peak (T0 + 20 minutes) and after a recovery period (T0 + 60 minutes).

In addition, the day following each assessment session, participants will be asked to apply mobile health patches for ambulant recording of their cardiac activity for a duration of 24 hours. At the same time, stress reactivity in daily life will be assessed using the experience sampling method. To this end, participants will be prompted on their smartphones at semi-random moments during the daytime to indicate how they are feeling for 4 consecutive days (10 prompts per day). Finally, in the morning of each assessment day, participants will collect salivary samples for the assessment of cortisol and oxytocin levels.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Vlaams Brabant
      • Leuven, Vlaams Brabant, Belgium, 3000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Provided written informed consent;
  • Dutch or English speaking;
  • Experience mild to severe stress symptoms (as measured by a score between 15 and 33 on the Stress Subscale of the DASS-21).

Exclusion Criteria:

  • History of psychotropic medication usage in the past six months;
  • Substantial experience with meditative practices (including but not limited to mindfulness, yoga, tai chi, or other similar practices) by meeting any of the following criteria:

    1. Participant has participated in a multi-day meditation retreat or program during the past year;
    2. Participant engages in meditative practices on a weekly basis or more frequently, for at least six consecutive weeks, within six month prior to the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Individuals assigned to this group will receive the experimental neurofeedback training
Neurofeedback training involving auditory feedback upon measurement of non-harmonic alpha-theta ratios during focused attention meditation
Sham Comparator: Control group
Individuals assigned to this group will receive the sham neurofeedback training
Sham neurofeedback involving auditory feedback at random timepoints during focused attention meditation such that no learning can take place

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
occurrence of non-harmonic alpha-theta ratios at rest
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
EEG recording
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
occurrence of non-harmonic alpha-theta ratios during meditation
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
EEG recording
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
occurrence of non-harmonic alpha-theta ratios during stress induction
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
EEG recording
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
occurrence of non-harmonic alpha-theta ratios during stress recovery
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
EEG recording
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
self-reported levels of emotional distress
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
DASS questionnaire
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-reported levels of mindfulness skills
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
CHIME questionnaire
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
self-reported levels of perceived stress
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
PSS questionnaire
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
self-reported levels of repetitive negative thinking
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
PTQ questionnaire
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
self-reported levels of sleep quality
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
PSQI questionnaire
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
mood state during training sessions
Time Frame: during each training session (i.e., twice during week 1, 2, 3, 4, and 5)
POMS questionnaire + single items (fatigue, focus, sleepiness) (exploratory)
during each training session (i.e., twice during week 1, 2, 3, 4, and 5)
salivary oxytocin levels
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
saliva sample (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
salivary cortisol levels
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
saliva sample (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
mood in daily life
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
experience sampling method (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
cardiac activity in the lab
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
ECG recording (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
cardiac activity in daily life
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
ECG recording (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
respiratory activity in the lab
Time Frame: pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)
respiration recording (exploratory)
pre-intervention (week 0), post-intervention (week 6), follow-up (week 11)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Kaat Alaerts, PhD, KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2024

Primary Completion (Estimated)

May 6, 2025

Study Completion (Estimated)

June 6, 2025

Study Registration Dates

First Submitted

December 21, 2023

First Submitted That Met QC Criteria

January 5, 2024

First Posted (Actual)

January 17, 2024

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • S68049

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Neurofeedback training

3
Subscribe